Company profile
BIMI International Medical Inc.
OTC: BIMI · Healthcare · Medical - Pharmaceuticals
PublicHQ New York, CIK 0001213660Reports USD
#612 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ 42GM —SS 52
v0.1 · 25/100 weight · pillars only
↑ 3-yr revenue growth, disclosure history · ↓ market scale, growth stability
Methodology →Revenue TTM
$5.8M
Rev growth YoY (TTM)
-65.7%
Net income (FY)
-$22.4M
Employees
296
as of 2026-07-19
Market cap
$1.2k
as of 2026-07-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$11.8M$11.8M2022
Net income-$22.4M-$22.4M2022
Operating income-$15.3M-$15.3M2022
Total assets$35.7M$35.7M2022
Liabilities$30.5M$30.5M2022
Equity$4.0M$4.0M2022
Revenue trend
FY2014 – FY2022 · USD
FY14
FY15
FY16
FY17
FY19
FY21
FY21
FY22
Revenue by segment
Filed disclosures · FY2022
By product
Others Member100%
By geography
Not disclosed.
The read
What is BIMI International Medical Inc.’s revenue?
BIMI International Medical Inc. booked $11.8M in FY2022 revenue, contracting 56% year over year — slower than 83% of Healthcare companies we track, at a -189.3% net margin.
Peers · Healthcare
Devonian Health Group Inc.46DPrelude Therapeutics Incorporated37DEscalon Medical Corp.63CJaguar Health, Inc.38DNEXGEL, Inc.51DCaribou Biosciences, Inc.43DKey facts
CEOTiewei Song
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersNew York, null
ExchangeOTC: BIMI
Employees296
IPO date2006-10-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.